siRNAs targeted to gene promoters can direct epigenetic modifications that result in transcriptional gene silencing in human cells. It is not clear whether the antisense strand of the siRNAs bind directly to DNA or to a sense-stranded RNA transcript corresponding to the known promoter region. We present evidence that an RNA polymerase II expressed mRNA containing an extended 5 untranslated region that overlaps the gene promoter is required for RNA-directed epigenetic modifications and transcriptional silencing of the RNA-targeted promoter. These promoter-associated RNAs were detected by their hybridization to the antisense strand of the complementary promoter-directed siRNA. Antisense phosphorothioate oligodeoxynucleotides were used to degrade the promoter-associated RNA transcripts, the loss of which abrogated the effect of siRNA-mediated transcriptional gene silencing, as well as the complexing of the siRNA with the silent state histone methyl mark and the promoter-associated RNA. These data demonstrate that low-copy promoter-associated RNAs transcribed through RNAPII promoters are recognized by the antisense strand of the siRNA and function as a recognition motif to direct epigenetic silencing complexes to the corresponding targeted promoters to mediate transcriptional silencing in human cells.
T
he histone code was proposed to explain the role of epigenetic modifications of histones in gene regulation (1) . Control of the histone code through specific targeted epigenetic marks could prove invaluable for long-term modulation of gene expression in treating diseases involving deregulated genes. However, the underlying mechanism responsible for governing the histone code is not yet well understood. Recently, it has become clear in human cells that siRNAs can modulate gene transcription in both a suppressive and activating manner through epigenetic modifications (2-4) suggestive of a role for RNA in directing the histone code. In human cells, RNAdirected transcriptional gene silencing (TGS) (2) can be initiated through promoter-targeted siRNAs and requires Argonautes 1 and 2 (5, 6) . The resulting siRNA-targeted promoter exhibits a silent state histone methyl mark containing both histone H3 lysine-9 di-methylation (H3K9me2) and histone H3 lysine-27 tri-methylation (H3K27me3) (7, 8) . Furthermore, RNA polymerase II appears to be required for siRNA-mediated TGS in both Schizosaccharomyces pombe (9, 10) and human cells (6, 7) . However, exactly how the siRNAs recognize and modulate TGS through histone methylation specifically at the targeted promoter has remained unclear. In S. pombe, transcription through the targeted genomic region is required for TGS (11) , suggesting that there might also be a role for transcription through promoter regions in human cells.
Results and Discussion
To determine whether TGS of the elongation factor 1 alpha promoter (EF1a) in human cells (2) involves an RNA transcribed through the promoter, we performed a pull-down assay using various species of 5Ј biotin-linked RNAs that target the EF1a promoter [supporting information (SI) Fig. 5 ]. Interestingly, we observed that only the 5Ј biotin-linked antisense strand of the EF1a promoter-targeted siRNA consistently eluted with a lowcopy RNA transcript corresponding to the EF1a promoter [supporting information (SI) Fig. 6 ]. This EF1a promoterassociated RNA was detected by reverse transcription (RT), using either a polydTT or an EF1a promoter-specific primer (Fig. 1A) . The detection of the promoter-associated RNA in elutes from pull-downs was inhibited by RNase A and resistant to RNase H treatment (Fig. 1B) , suggesting that the antisense RNA-mediated pull-down was specifically an RNA/RNA interaction and not an RNA/DNA interaction and that this RNA contained a poly(A) tail. To reconfirm the pull-down assay, we performed directional RT-PCR on total RNA extracted from cell cultures (Fig. 1C ). Supporting observations with the pulldown assay, only the antisense primer (relative to the direction of mRNA transcription) was capable of amplifying the EF1a promoter-associated RNA (Fig. 1D) , which when sequenced exhibited direct sequence homology to the known EF1a promoter (GenBank accession no. DQ503424).
The observation that there is transcriptional activity across the EF1a promoter suggested that a species of RNA is generated specifically to promoter regions. To characterize the 5Ј end and transcription start site (TSS) of this EF1a promoter-associated RNA, 5Ј RACE was performed. The 5Ј RACE procedure identified the promoter-associated RNA TSS to be Ϸ230 bp upstream of the previously described TSS for EF1a ( Fig. 1E ; GenBank accession no. DQ642693) in a region that does not appear to be required for promoter activity (12) .
Although the 5Ј RACE indicated substantial overlap with the defined EF1a promoter (12) , the 3Ј end remained unknown. To determine whether the promoter-associated RNA was linked to the mRNA coding region 3Ј RACE was performed by using primers defined from the previously performed 5Ј RACE (Fig.  1E) . Interestingly, the 3Ј RACE product produced a transcript that contained both the newly defined upstream 5Ј UTR of the EF1a promoter-associated RNA and the intron-spliced and -processed EF1a mRNA ( Fig. 1E ; GenBank accession no. EF362804). The 5Ј and 3Ј RACE sequence data thus suggested that this promoter-associated RNA was in essence a variant mRNA that contained an extended 5Ј UTR (Ϸ230 bp upstream of the transcription start site) and was functional, because it was spliced and processed in a manner similar to RNA polymerase II (RNAPII) transcribed EF1a transcripts (Fig. 1E) .
The requirement for a biotin-linked pull-down assay to detect this RNA variant suggested that the expression level of the promoter-associated RNA variant is relatively low compared with mRNA expression levels. To determine the prevalence of the endogenous EF1a promoter-associated RNA, we performed quantitative RT-PCR for EF1a promoter-associated RNA variant and mRNA in five different cell types. On average, there was Ϸ571 EF1a mRNA copies/promoter-associated RNA variant copy (Table 1) . Taken together, these observations suggest that an EF1a promoter-associated low-copy sense-stranded RNA, with an extended 5Ј UTR, is present and interacts with the antisense strand of the EF1a promoter-targeted siRNA, supporting findings depicting a functional role for the antisense strand of siRNAs and RNAPII in TGS of human cells (7) .
The extent of transcription through RNAPII promoters is currently unknown. To determine how ubiquitous these promoterassociated RNA variants are, we surveyed various cell types, using quantitative RT-PCR. We screened the EF1a, p16, NF-B, and Cyclin D1 promoters to contrast mRNA and promoterassociated RNA variant expression levels standardized to GAPDH mRNA levels in 293T, 293-R5-GFP, 1G5, and THP-1 cell lines and primary cell types BJ and HuVEC. In the cell types examined, each assayed gene exhibited similar mRNA to promoter-associated RNA variant ratios (Table 1) , further supporting the 5Ј and 3Ј RACE data that suggests promoter-associated RNA variant expression is linked with mRNA expression across various genes in numerous cell types. . Samples from the preelution step (Input) are shown along with the post-biotin/avidin elution (Elution). The elutes were collected 24 h after transfection, DNase treated, subject to RT with either a random hexamer primer (dTT) (BioRad; iScript), or EF1a-specific primer (EF1a) that spans the EF1a promoter/exon 1 junction (SI Table 2 , no. 804) and PCR amplified with EF1a-specific primers (SI Table 2 , 803/804). (B) The 5Ј biotin tagged antisense RNA eluted EF1a promoter-associated RNA is sensitive to RNase A and resistant to RNase H treatment. Sample lanes represent elutes from cultures treated with (1) EF52 sense RNA ϩ 5Ј biotin linker, (2) EF52 antisense RNA ϩ 5Ј biotin linker, and (3) EF52 sense RNA plus 5Ј biotin linker annealed to the EF52 antisense plus 5Ј biotin linker. The resultant elutes underwent RT (BioRad; iScript) followed by PCR (SI Table 2 , EF1a-specific primers 803/804) after the various RNase treatments. (C) Characterization of the EF1a promoter-associated RNA as determined by bidirectional RT-PCR. RT was performed on DNase treated 293T cell RNA with various primers either sense (1) or antisense (2) (SI Table 2 , 803 or 805, respectively) followed by PCR with both primers. (D) RT with primer 2 followed by PCR with primers 1 and 2 generates a Ϸ156-bp band corresponding to the EF1a promoter whereas RT with primer 1 followed by PCR with primers 1 and 2 does not. The results from three independent cultures are shown. (E) 5Ј and 3Ј RACE analysis of the EF1a promoter-associated RNA was performed on 293T cell RNA with EF1a primers specific for the promoter-associated RNA. The 5Ј RACE analysis was performed with primer 5 (SI Table 2 , EFpRNARev), whereas the 3Ј RACE analysis was performed with the 3ЈRACE F primer (SI Table 2 ). The resulting RACE products were cloned, sequenced, and shown to be spliced and processed accordingly and to contain a 5Ј UTR which overlaps Ϸ230 bp of the EF1a promoter.
Next, we investigated whether the EF1a promoter-associated RNA variant was susceptible to siRNA-mediated targeting and suppression. Transient transfections of synthetic EF1a-targeted siRNAs demonstrated a reduction in both the EF1a promoterassociated RNA and mRNA levels at 24 h after siRNA transfection ( Fig. 2A) , which was similar to, but not as robust as, previous observations of EF1a TGS observed at 48 h after siRNA transfection (2, 6, 7) . These data indicate that the EF1a promoter-associated RNA variant, similar to EF1a transcribed mRNAs, is also reduced in expression when targeted by siRNAs.
To ascertain the requirement of the promoter-associated RNA variants for the induction of siRNA-mediated TGS, we performed a blocking experiment in which antisense phosphorothioate oligodeoxynucleotides (ODNs) (13) were designed to recognize the cognate promoter-associated RNA variant sequence for either the EF1a or CCR5 promoters. The CCR5 promoter was recently shown to be susceptible to siRNAdirected TGS (6) in a manner similar to observations with EF1a (2). Phosphorothioate ODNs operate by Watson-Crick hydrogen bonding to inhibit RNA expression by activation of the RNase H pathway, which cleaves the targeted RNA at the heteroduplex site (14) . When promoter-associated RNA variant expression was directly assessed in phosphorothioate ODN treated cultures, there was a specific and significant reduction in promoter-associated RNA expression of both the EF1a (Fig. 2B ) and CCR5 promoter-associated RNAs (SI Fig. 7A ) after ODN treatment. The suppression of the EF1a promoter-associated RNA by ODN treatment did not significantly reduce the downstream EF1a mRNA expression (SI Fig. 8 ). These data suggest that the phosphorothioate ODNs are functional in suppressing promoter-associated RNA expression for either EF1a or CCR5.
To determine the ability of EF1a promoter-directed siRNAs to modulate TGS in the absence of the low-copy EF1a promoterassociated RNA, cultures were first treated with the EF1a-specific ODN followed by a transfection with the EF1a-targeted siRNAs (either antisense RNA or siRNA). Interestingly, there was a concurrent loss of RNA-mediated TGS, whereas the control, ODNs-targeted to the CCR5 promoter, had no effect on RNA-directed transcriptional silencing of the EF1a promoter ( Fig. 2C and SI Fig. 7B ). The EF1a-specific ODN treatment was also effective at suppressing the detection of the EF1a promoterassociated RNAs in the 5Ј biotin pull-down assay, whereas the control ODN had no effect (SI Fig. 9) . A similar observation of ODN-mediated blocking of TGS was observed when the CCR5-specific ODN was used to block RNA targeting of the CCR5 promoter (SI Fig. 7B ). Overall, these data indicate that EF1a and CCR5 promoter-associated RNA variants play a functional role in the induction of RNA-mediated TGS in human cells.
TGS in human cells has been shown to operate through epigenetic modifying complexes and specifically correlate with a corresponding silent state histone code at the siRNA-targeted promoter (5-7). To determine the requirement of the promoterassociated RNA variant in directed epigenetic modifications that can result in gene regulation, dual pull-down experiments were performed. Suppression of the EF1a promoter-associated RNA variant expression by ODN treatment resulted in a loss of siRNA-directed H3K9me2 at the siRNA-targeted EF1a promoter (Fig. 3A) and an inability to elute the EF1a-targeted promoter with H3K9me2 and the EF1a-specific 5Ј biotin-linked RNA (Fig. 3B) . These data suggest that siRNA-targeted chromatin remodeling complexes require the promoter-associated RNA to modulate epigenetic modifications, but do not directly link the promoter-associated RNA with the respective silent state chromatin mark for the targeted gene. To determine whether the EF1a promoter-associated RNA variant is directly linked to the respective silent state chromatin mark a dual pull-down assay was performed, followed by DNase treatment of the elutes, which were then assayed specifically for the promoter- The mRNA and pRNA expression for EF1-alpha, p16, NF-kB (p105 subunit), and Cyclin D1 was determined by real-time quantitative PCR and standardized to GAPDH from RNA isolated from various human cell lines and primary cells.
associated RNA variant. Interestingly, when the EF1a promoterassociated RNA variant was suppressed by ODN treatment there was no detectable EF1a promoter-associated RNA variant in the dual pull-down whereas the control was capable of eluting the EF1a promoter-associated RNA variant along with the H3K27me3 silent state epigenetic mark (Fig. 3C ). These data directly link the 5Ј biotin-linked antisense strand of the EF1a-targeted RNA, the H3K27me3 epigenetic mark, and the EF1a promoter-associated RNA variant and support the notion that the promoter-associated RNA variant described here is required for RNA-directed silent state histone methyl marks and transcriptional silencing in human cells. We describe here that the EF1a, CCR5, p16, NF-B, and Cyclin D1 RNAPII promoters in various human cell lines and primary cells contain corresponding RNA transcripts, overlapping their respective promoter regions and in particular the promoter-directed siRNA target sites for EF1a and CCR5. These promoter-associated RNA variants are recognized by the antisense strand of promoter-targeted siRNAs and are reduced after siRNA treatment concomitantly with mRNA expression levels. These data suggest that promoter-associated RNA variants transcribed through RNAPII promoters are recognized by the antisense strand of the siRNA, and possibly other forms of antisense RNA, to mediate epigenetic modifications at the RNA-targeted loci in human cells. Indeed, species of RNA similar to promoter-associated RNA variants have been observed to span intergenic regions and appear to be coupled to chromatin remodeling complexes in controlled expression of repetitive RNA genes in human cells (15, 16) , although in the human dihydrofolate reductase gene, a noncoding upstream initiated RNA has been shown to act as a promoter interfering transcript (17) and in S. pombe a similar RNA has been shown to be involved in argonaute-mediated slicing and transcriptional silencing (11) . Interestingly, higher order chromatin structures appear to contain an uncharacterized RNA component that may function as a scaffolding in chromatin remodeling (18) . These data, along with observations that antisense transcription appears to be ubiquitous in human cells (19) , are suggestive of an endogenous mechanism by which antisense RNAs can function by interactions with the promoter-associated RNA variants to direct specific epigenetic modifications in human genetic diseases (20, 21) , gene regulation (22, 23) , and possibly be used in establishing or maintaining HIV-1 latency (24) . Indeed, the antisense strand of the siRNA is required to initiate TGS in human cells (7), suggesting a biological function for the sensestranded promoter-associated RNA variants described here. Interestingly, the antisense strand of siRNAs appear to be more stable and preferentially compartmentalized within the cell (25), possibly implicating a role for antisense RNAs in regulating pseudogenes (26) or retroelements in human cells (27) putatively through interactions with promoter-associated RNA variants spanning these genomic regions.
A model has begun to emerge that is based on initial work in S. pombe and expounded on here that explains the functional and mechanistic role of the promoter-associated RNA variants in RNA-mediated transcriptional gene regulation in human cells. The promoter-associated RNA model of transcriptional silencing might function by RNAPII reading through the promoter, transcribing a relatively low-copy promoter-associated RNA variant, which can become bound by targeted antisense RNAs (Fig. 4) . The promoter-associated RNA variant and antisense RNA complex might then associate with the local chromatin architecture through a yet-to-be defined chromatin remodeling complex possibly containing DNMT3A. DNMT3A has been shown to bind siRNAs (28) and coimmunoprecipitate with the antisense strand of EF1a promoter-specific siRNAs and H3K27me3 at the targeted EF1a promoter (7). This bound complex could then permit the docking of a chromatin remodeling complex that can initiate the writing of a silent state histone code at the targeted promoter and possibly spreading distal of the siRNA-targeted site in a 5Ј-3Ј manner along with transcription (6, 7). Such a scenario would accommodate previous observations in which siRNAs have been shown to interact with various components of chromatin remodeling complexes (5-7). Of significant interest is the role DNMT3A might play in siRNA-mediated TGS and/or antisense RNA-directed chromatin modifications. DNMT3A has not only been shown to interact with siRNAs (7, 28) but also to coimmunoprecipitate with the H3K27 methyltransferase EZH2 (29), HDAC-1, and Suv39H1 (30) . Moreover, EZH2 and Ago-1 have both recently been observed at siRNA-targeted promoters and suppression of Ago-1 inhibits siRNA-mediated TGS (5, 6) , suggesting a link between RNAi and chromatin remodeling components. The observations presented here, that promoter-associated RNA variants are present at siRNA-targeted promoters, combined with the requirement of RNAPII in siRNA-mediated TGS (6, 7, 10) and the coimmunoprecipitation of DNMT3A and H3K27me3 with siRNAs and the siRNA-targeted promoter (7, 28) , provide a link between RNA, chromatin, and gene expression. Overall, these data support a role for siRNAs, and specifically antisense-stranded RNAs, in writing the histone code (1) and the regulation of gene expression. These findings may lead to new therapeutic approaches in directed epigenetic control of gene expression in human cells. Eighteen to 24 h after the siRNA transfection the ODN/siRNA transfected cultures were collected and cell RNA isolated and used in qRT-PCR for EF1a mRNA, EF1a promoter-associated RNA variant, GFP mRNA, or CCR5 promoter-associated RNA variant detection (described in SI Methods). For the ODN blocking of the pull-down assay the cultures were collected, and detection of promoter-associated RNA variants were determined from the promoter-associated RNA pull-down elutes (described in SI Methods). promoter-associated RNA variant coimmunoprecipitates with the H3K27me3 epigenetic mark and the 5Ј biotin-linked antisense EF1a-specific RNA. Dual pull-down assays were performed on 293T cultures treated with either the EF1a-specific (EF1a) or CCR5-specific (CCR5) ODNs (100 nM) transfected 4 h later with the 5Ј biotin-linked EF1a-specific antisense RNA (EF52as, 100 nM). Twenty-four hours later, cultures were collected and an H3K27me3 immunoprecipitation (ChIP) was performed followed by a biotin/avidin pull-down on the H3K27me3 elutes. The resultant elutes were then subject DNase treatment, and a reaction was carried out with or without reverse transcriptase (ϩRT or ϪRT, respectively). The samples were then subject to nested PCR specific for the promoter-associated EF1a RNA variant. The result from one of two such experiments is shown. (C) The initial silencing event or prolonged suppression of the siRNA-targeted promoter may result in heterchromatization of the local siRNA-targeted genomic region and is not, based on these data, thought to be the result of slicing of the low-copy promoterassociated RNA but rather due to a recruitment of chromatin remodeling factors or complexes to the targeted promoter that result in the gene silencing event.
Materials and Methods

